This Week in Psychedelics - 1.21.22

Cannabis

• Thailand Plans to Make Marijuana Legal, Scrapping Jail Terms and Fines for Possession (Bloomberg)

• U.S. Senate Candidate Smokes Marijuana Blunt In Campaign Ad About Harms Of Criminalization (Marijuana Moment)

• After One Year As President, Biden’s Marijuana Promises Remain Unfulfilled (Marijuana Moment)

• Mississippi House Approves Medical Marijuana Bill With Amendments (Marijuana Moment)

• It’s high time that people caught with cannabis be spared jail, declare public (The Telegraph)

• London’s Cannabis Diversion Plan Draws Political Fire (Filter)

• Kansas Medical Marijuana Hearings Cancelled After Senate GOP Leader Reroutes House-Passed Bill (Marijuana Moment)

• What Is THC-O Acetate, And Why Is It Getting Attention? (Forbes)

• Study Shows Cannabis was Food Staple for Ancient Chinese Dynasty (High Times)

• Most Americans Predict Biden Won’t Uphold Marijuana Decriminalization Promise In 2022, Poll Finds (Marijuana Moment)

• Austin, Texas Cannabis Decriminalization Initiative Set for Ballot in May (High Times)

• Rhode Island Governor Includes Marijuana Legalization And Expungements In Budget Request (Marijuana Moment)

• Cannabis use impacts cognitive ability beyond intoxication: study (CTV News)

• Minnesota Democratic Leaders Preview Marijuana Legalization Plan For 2022 (Marijuana Moment)

• Ohio Advocates Submit Additional Signatures for Cannabis Proposal (High Times)

• Kentucky Addresses Cannabis Reform Through New Legislation (High Times)

• Canada might be home to the world’s first airport dispensary (Leafly)

• Nebraska Activists Say New GOP Medical Marijuana Bill Is A ‘Poison Pill’ Meant To Detract From Ballot Efforts (Marijuana Moment)

• South Dakota Governor Demands Cannabis Advocates Cover Legal Costs (High Times)

• Banking Activity Increases In States That Legalize Marijuana, Study Finds (Marijuana Moment)

• Cannabis Companies Target Teens on Social Media, Study Claims (High Times)

• Cloudastructure’s Artificial Intelligence is Revolutionizing Cannabis Surveillance (High Times)

Magic Mushrooms

• Controversial Kansas Lawmaker Files Bill To Legalize Psilocybin Possession And Cultivation (Marijuana Moment)

• Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients (Marijuana Moment)

• New Research Probes Psilocybin’s Effect on Suicidality (Lucid News)

• Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent (Psilocybin Alpha)

MDMA

• Why MDMA Makes You Horny (VICE)

• Use of ecstasy and cocaine drops during pandemic (Irish Examiner)

• Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial (Psilocybin Alpha)

• The MDMA Comedown: Why Coming Down From Molly Feels So Bad (DoubleBlind)

• A psychedelic trip to recovery: How psychedelics can help treat PTSD (The Ubyssey)

DMT

• Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study (Psilocybin Alpha)

• Why Do People See Elves And Other "Entities" When They Smoke DMT? (IFLScience)

Ayahuasca

• Do Ayahuasca Healing Ceremonies Really Work? (Psychology Today)

Morning Glory Seeds

• What Is LSA? Your Guide To The Complicated Psychedelic (Healing Maps)

Novel Psychoactive Substances

• BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001 (Psilocybin Alpha)

Synthetic Cannabinoids

• Study: Cannabinoids May Help Prevent and Treat Peanut Allergies (The Marijuana Herald)

• Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity (Medscape)

• Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process (GlobeNewswire)

Ketamine

• Plastic Surgeons Are Using Ketamine to Make Nose Jobs More Pleasant (Allure)

Datura

• Are your food grains adulterated with poisonous dhatura (Times of India)

Miscellaneous

• DEA Proposes Adding 5 More Psychedelics to Schedule 1 Controlled Substances (Psychedelic Spotlight)

• Psychedelic use is only “weakly” associated with psychosis-like symptoms, according to new research (PsyPost)

• Utah Lawmaker Files Bill To Explore Therapeutic Use of Psychedelics (High Times)

• Psychedelics ‘Train Has Left the Station’ Says Federal Drug Official as More States Seek Access (Psychedelic Spotlight)

• Sydney Researchers Awarded Over $2.2 Million By Australian Government To Study MDMA, Psilocybin (Forbes)

• Missouri Lawmaker Files Bill To Decriminalize Low-Level Drug Possession (Marijuana Moment)

• Psychedelic legalization now (The New Amsterdam Psychedelic Law Blog)

• Psygen Receives Dealer’s Licence To Become Canada’s First Dedicated Psychedelics Manufacturing Facility (The Dales Report)

• Allowing psychedelic assisted therapy is an enlightened move, medical experts say (National Post)

• Majority of Mental Health Patients Support Access to Psychedelics, Survey Finds (Psychedelic Spotlight)

• Psychedelic Company Highlights in 2021 (Psilocybin Alpha)

• Talking Drugs Updates from Eastern Europe and Central Asia (TalkingDrugs)

• Pandemic Tripping With Psychedelics (Green Market Report)

• What are the potential risks of microdosing psychedelics? (Leafly)

• Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology (Psychedelic Spotlight)

• Peek Inside Philadelphia’s Psychedelics Revolution (Philadelphia Magazine)

• Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II (Psilocybin Alpha)

• How Port Townsend, Washington, Decriminalized Psychedelics (Filter)

• Athletes and Psychedelics: Mental Health and Performance (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.23.21

Cannabis

• Cops Will No Longer Bust People for Weed at New York Airports (MERRY JANE)

• Redlining in Cannabis is Cutting Off Opportunity For Black People. (Chicago Defender)

• Medical Marijuana Patient Sues Polis Over New MMJ Laws (Westword)

• The Pernicious Myth of Fentanyl-Laced Cannabis (Filter)

• Virginia's “Marijuana Martyr” Is Now Smoking Legal Weed 48 Years After His Arrest (MERRY JANE)

• Another North Carolina Senate Committee Approves Medical Marijuana Legalization Bill (Marijuana Moment)

• Study: Cannabis Use Not Linked to Motivation Loss (NORML)

• Missouri Marijuana Activists File Legalization Initiatives For 2022 As Other Groups Prepare Separate Measures (Marijuana Moment)

• High-Potency THC Concentrates Are Just As Safe As Regular-Potency Weed, More Data Shows (MERRY JANE)

• Mississippi Lawmakers Aim To Pass Medical Marijuana Bill In August Special Session After Ballot Measure Blocked By Court (Marijuana Moment)

• The future of cannabis is female: Gen Z women are fastest-growing consumers of legal weed (NBC News)

LSD

• Performance-enhancing psychedelics: Can LSD make you better at sport? (New Atlas)

• Mississippi city settles over case of man who had taken LSD, then died after police used Taser to restrain him (Magnolia State Live)

Magic Mushrooms

• The Magic Mushroom Map shows likely spots for psilocybin-containing mushrooms (Boing Boing)

• The Other Magic Mushroom: Why a Canadian Startup is Suddenly Interested in the Fungus From Super Mario (Discover Magazine)

• Mouse Study Reveals New Details on Psilocybin’s Rewiring of the Brain (Psychedelic Science Review)

• Expert: Psilocybin Treatment May Support Patients With Obesity Who Have Tried Everything, Need Further Support (Pharmacy Times)

• Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan (Psilocybin Alpha)

MDMA

• AOC Promotes Research On Benefits Of Psychedelics Like Psilocybin And MDMA With New Amendment (Marijuana Moment)

• MDMA as a Potential Treatment for PTSD (Reality Sandwich)

DMT

• Could DMT Sweep Existing Treatments for Depression Aside? (MarketWatch)

Ayahuasca

• The Good, The Bad, and the Soul: Drug Interactions and Ayahuasca with Ben Malcolm (EntheoNation)

5-MeO-DMT

• Sonora’s traditional toad medicine ‘removes the madness from your mind’ (Mexico News Daily)

Iboga

• Lamar Odom Reveals ‘Ibogaine’ Use To Treat Drug Addiction In Explosive New Interview (The Blast)

Novel Psychoactive Substances

• Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds (Psilocybin Alpha)

Nitrous Oxide

• Is Nitrous Oxide a Psychedelic Drug? (Psychedelic Science Review)

Ketamine

• Ireland trials use of ketamine to treat depression (Irish Central)

• Braxia Scientific says ketamine treatment now covered by insurance for Canadian military and RCMP veterans (Proactive Investors)

• Sublingual Ketamine Is Safe and Effective for Management of Chronic Nonmalignant Pain (Clinical Pain Advisor)

• Ketamine Therapy and Addiction Risk Management: Part II (Truffle Report)

• PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation (Psilocybin Alpha)

• Mindful Use of Nitrous Oxide: How to be a Connoisseur of Getting High (Maps of the Mind)

• What Neurotransmitters Does Ketamine Affect Most In The Brain? (Healing Maps)

Miscellaneous

• Is It Too Early to Invest in Psychedelic Stocks? (Nasdaq)

• Why Mindfulness Practitioners are Better Positioned to Trip on Psychedelics (DoubleBlind)

• How Freaks of Color Shaped Psychedelia (Lucid News)

• From Screening to Integration: Harm Reduction in Psychedelic Research (Psychedelic Science Review)

• Psychedelic Surrender (Maps of the Mind)

• Psychedelics Are Not a Mental Health Panacea (Sam Woolfe)

• Towards a More Rational and Compassionate Drug Policy (Dr. Bronner's)

• Psychedelic Activity Menus: Having Options for Your Session (Maps of the Mind)

• What Is Depth Psychology and How Does It Relate to Psychedelics? (Psychedelics Today)

• Are Potentially Legal Psychedelics Safe For Pregnant Women? (Healing Maps)

• Psychedelic Therapeutics Startup Cybin To List On NYSE’s Small Cap Market (Forbes)

• Could Psychedelics Help Prevent Mental Health Problems? (Kahpi)

• Working at Legal Psychedelic Retreats Around The World (Maps of the Mind)

• Psychedelics and Queerness (Reality Sandwich)

• What International Drug Users Remembrance Day Means to Me (Filter)

• Chelsea Osmond: Linking the Past and Future of the Psychedelic Renaissance (Chacruna)

• Creating Music Playlists for Psychedelic Journeys (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.16.21

Cannabis

• Schumer, Senate Democrats unveil new bill to decriminalize marijuana (The Hill)

• Can Marijuana Make You a Better Athlete? (The New York Times)

• Missouri Man Released From Prison After Serving 11 Years for Possessing One Pound of Weed (MERRY JANE)

• Cannabis vs. HIV: UNC researcher lands $4M grant to explore possibility (WRAL Tech Wire)

• DEA Approves Denver Marijuana Facility for Medical Research (Westword)

• Tennessee Republican Lawmaker’s New Bill Would Put Three Marijuana Questions Before Voters On 2022 Ballot (Marijuana Moment)

• Michigan governor moves to regulate delta-8 THC products (Marijuana Business Daily)

• Missouri Governor Vetoes Medical Marijuana Tax Deduction Bill (Marijuana Moment)

• Analysis: Marijuana Legalization Correlates with Higher Home Values (NORML)

• Study Shows Cannabis Terpenes Provide Pain Relief, Contribute to ‘Entourage Effect’ (The University of Arizona Health Sciences)

• Cannabis may have originated in northwest China, study suggests (Henry Herald)

LSD

• Auckland University researchers to trial LSD microdoses on advanced-stage cancer patients (Newshub)

• LSD vs. Acid: A Brief History of Acid Slang (DoubleBlind)

• Calls to reclassify LSD out of class A as mental health research picks up steam (Newshub)

• Genetic Determinants of the LSD Response (Psychedelic Science Review)

Magic Mushrooms

• Psilocybin Mushrooms in Mexico in Danger of Extinction (Chacruna)

• Living In Peace: Cancer Patients Extralegally Seeking Psilocybin-Assisted Psychotherapy Amid DEA Suit (Maps of the Mind)

MDMA

• Vancouver psychedelics company gets Health Canada greenlight for MDMA therapy study (CBC)

• The Re-Emergence of Ecstasy - But Not at the Club (JD Supra)

Ayahuasca

• DMT, active component in ayahuasca, aids in the growth of new neurons (PsyPost)

• First Study on Psychedelics and Epigenetics Explores Ayahuasca’s Effects on Gene Expression (Lucid News)

• Megan Fox Said She Went To “Hell For Eternity” During A Hallucinogenic Tea Trip With Machine Gun Kelly And It “Bonded” Them Even More (BuzzFeed News)

• The Ayahuasca Experience: A Pilgrimage to the Spirit (DoubleBlind)

• Lessons From Ayahuasca (Maps of the Mind)

5-MeO-DMT

• From Hunter Biden To HGTV Star Christina Haack, Psychedelic Toad Venom Hits The Mainstream (Forbes)

Peyote

• The Traditional & Medicinal Use of Peyote in North America with Oscar Matzuwa (EntheoNation)

Iboga

• MINDCURE Announces Filing of U.S. Provisional Patent Applications for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound (Psilocybin Alpha)

Synthetic Cannabinoids

• The Rise in Synthetic Cannabinoids and Cathinones (Psychiatric Times)

Ketamine

• Microdoses of psilocybin and ketamine enhance motivation and attention in rodent models relevant to depression (PsyPost)

• Ketamine, esketamine do not differ in cognitive effects for treatment-resistant depression (Healio)

• Dissociation as Medicine? Exploring Dissociation & Dissociative Psychedelics like Ketamine (Psychedelics Today)

• Ketamine-Assisted Psychotherapy for Frontline Workers (Truffle Report)

• Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction (Psilocybin Alpha)

• Ketamine Therapy and Addiction Risk Management: Part I (Truffle Report)

• Here’s How Ketamine Affects The Brain (Healing Maps)

Miscellaneous

• California Bill To Legalize Psychedelics Possession Advances Again, With New Amendments That Add Limits (Marijuana Moment)

• In the Light of Dying Stars (Here and Now Studios)

• Ethan Nadelmann Reexamines Adult Drug Use in New Podcast ‘Psychoactive’ (Rolling Stone)

• Biden Selects White House Drug Czar Who Helped Implement State Marijuana Program And Touted Medical Benefits (Marijuana Moment)

• World Reimagined: The Growth of the Psychedelic Industry (Nasdaq)

• Syncing Psychedelic Sessions with Moon Cycles (Maps of the Mind)

• Advocacy Group Asks to Delay California Psychedelics Bill Until 2022 (Truffle Report)

• Mass. Communities Move Toward Decriminalizing Psychedelics, With Some Pushback (WGBH)

• Shamanic Ceremony Leaders Join Forces to Shape Legal Strategy through the Sacred Plant Alliance (Lucid News)

• Can Coca Leaf Avoid the Wrongs of The Psychedelic Revolution? (Chacruna)

• Religious Access to Psychedelics is No Substitute for Decriminalization (DoubleBlind)

• Is public discourse on drug overdoses improving? (Drug WarRant)

• Active vs. Passive Coping Distinguishes Antidepressants and Psychedelics (Psychedelic Science Review)

• Food Suggestions for Before, During, and After Psychedelic Sessions (Maps of the Mind)

• Ultimate Guide on the Legalization and Decriminalization of Drugs (Reality Sandwich)

• Psychedelics and Death: Transitioning from this World with Consciousness (Chacruna)

• The interesting origins of psychedelic therapy (Freethink)

• New Frontiers in the Law of Psychedelics (JD Supra)

• Psychedelic Decriminalization Creating Market Opportunities (PR Newswire)

• Going Offline for Psychedelic Journeys (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.18.21

Cannabis

• Louisiana Governor Signs Marijuana Decriminalization Bill Into Law (Marijuana Moment)

• Texas: Governor Signs Medical Cannabis Expansion Legislation into Law (NORML)

• Connecticut Marijuana Legalization Bill Heads To Governor’s Desk (Marijuana Moment)

• Poll: 92 Percent of Americans Say Marijuana Should Be Legal Under Certain Circumstances (NORML)

• Florida Supreme Court Kills Another Marijuana Legalization Ballot Measure For 2022 (Marijuana Moment)

• Stoned Driving Is Far Safer Than Operating a Vehicle on Prescription Drugs, Study Says (MERRY JANE)

• Rhode Island Marijuana Legalization Bill Approved In Senate Committee (Marijuana Moment)

• Montana: Opponents Drop Lawsuit Challenging Voter-Approved Legalization Initiative (NORML)

• Two cannabis legalisation bills to be considered in Portugal (CanEx)

• Nebraska Marijuana Activists Plan ‘Mass Scale’ Medical Cannabis Campaign For 2022 Ballot (Marijuana Moment)

• Local Marijuana Decriminalization Efforts Launch In Ohio, South Carolina And West Virginia (Marijuana Moment)

• Wyoming Activists File 2022 Marijuana Decriminalization And Medical Cannabis Ballot Measures (Marijuana Moment)

LSD

• Could LSD Really Be a Better Smart Drug Than Modafinil? (Sam Woolfe)

Magic Mushrooms

• Oregon’s psilocybin program starts to take shape (OPB)

• Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin (Psilocybin Alpha)

• Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development (Psilocybin Alpha)

Ayahuasca

• How Ayahuasca Can Help Gay Men Create Better Dance Parties (Chacruna)

Novel Psychoactive Substances

• Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004 (Psilocybin Alpha)

Nitrous Oxide

• Laughing gas could help people with hard-to-treat depression (Popular Science)

Miscellaneous

• Federal Drug Decriminalization Measure Introduced in the House (DoubleBlind)

• Introducing the Mormon Psychedelic Summit (DoubleBlind)

• The problem at the heart of modern psychedelic clinical research (New Atlas)

• This Summer Might Be a Psychedelic Dumpster Fire. Are You Ready? (Lucid News)

• West Coast Psychedelic Update (Dr. Bronner's)

• Toronto board of health to ask Ottawa to decriminalize drug possession in the city (Toronto Star)

• Clinics Seek to Widen Access to Psychedelic Therapy for BIPOC Communities (Lucid News)

• Can Psychedelics Help Make Dying Easier? (Rolling Stone)

• Hippie Girls in Yorkville: Canada’s Haight-Ashbury (Chacruna)

• Whole-Body Effects of Psychedelics – Part 1 (Psychedelic Science Review)

• The Brain’s Psychedelic System (Reality Sandwich)

• As the Pandemic Wanes and the Party Kicks Off, Drug Testing and Safety Are More Important Than Ever (Lucid News)

• Consent is Psychedelic. Here’s Why. (DoubleBlind)

• Psychedelics and Surfing (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - May 2021

May was yet another busy one for psychedelic news, with plenty of drug policy reform progress, industry developments, groundbreaking research, and a couple controversial events taking place. In this month’s update we’ll dive into these topics and much more.

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Drug Policy

Wins

Two states made huge progress on cannabis reform. First, Montana’s governor signed a bill to implement the recreational marijuana program that voters approved last November. Retail sales for adults 21 and older will begin in January of next year. And continuing an emerging pattern of Southern states revamping cannabis laws, Alabama’s governor signed legislation to legalize medical marijuana in the state. The country is turning more and more green every month!

A few other bills made huge progress as well but have not crossed the finish line yet: an attempt to decriminalize psychedelics in California, legislation that would enable Texas to conduct psychedelic research, a cannabis legalization effort in Minnesota, and Switzerland is getting closer to legalizing marijuana as well.

Losses

Some bills hit a wall though. In Mexico lawmakers failed to legalize cannabis ahead of a Supreme Court deadline, Aspen’s city council chose not to decriminalize psychedelics, drug possession is now a misdemeanor in Washington State, Mississippi’s Supreme Court overturned a medical marijuana legalization ballot that voters approved last November, Colorado and New York banned delta-8 THC, China banned synthetic cannabinoids, and Amsterdam and a London borough banned nitrous oxide.

Future

Looking ahead, Republicans in the U.S. are pushing for the federal legalization of cannabis to ensure individual liberty, so legal weed in America is looking more and more like becoming a possibility sometime soon.

Industry

An NHL star’s brain trauma led him to found a psychedelic startup company, legal cannabis states have generated nearly $8 billion in tax revenue since recreational sales launched, Champignon Brands changed its name to Braxia Scientific, and MindMed announced Project Angie, the company’s attempt to treat pain with psychedelics.

Research

The results from MAPS’ Phase 3 trial of MDMA-assisted therapy for PTSD are in, and things are looking promising for this novel form of treatment. Out of 90 participants who enrolled in the study, the group which received MDMA during therapy experienced a more significant reduction in the severity of their PTSD symptoms compared to the placebo-controlled group. In fact, two months after treatment 67% of people in the MDMA group no longer qualified for a PTSD diagnosis whereas only 32% of the placebo group did. These results are promising and lend credence to the idea that MDMA will be legally available for medical use within the next couple years.

Other research studies found that psilocybin may be able to treat migraine headaches, how LSD opens the doors of perception, that frequent cannabis consumers are more physically active than non-users, and that actual drug education is far better than the government’s typical approach of “just say no.” In addition, the U.S. federal government announced a new standard THC dose to be used in cannabis research.

Miscellaneous

Causing a bit of a stir in the global psychedelic community, a publication known as Psychedelic Invest published a list of the 100 most influential people in psychedelics ranking candidates based on the following factors: social reach, scientific accomplishments, legislative initiatives, and value creation/contribution. The list was criticized for its lack of diversity, which prompted a public response acknowledging the fact the publication failed to prioritize the inclusion of a diverse group of people when creating it. In today’s political climate it’s no wonder that the publication of a list like this was heavily criticized, but the constructive reaction from Psychedelic Invest indicates that the publication is willing to learn from its mistake.

A new cannabis product generated an uproar on social media. Dubbed Canna Bumps, this unique cannabis concentrate looked kind of like cocaine and was intended to be snorted by consumers. Needless to say, it caught a lot of flack from industry insiders and judgmental marijuana smokers alike. Claiming that it would hurt the movement to legalize cannabis on a federal level, enough people complained that the product was quickly pulled from the market.

Now me personally, I can see how a product like this could be used by drug warriors to hurt the effort to reform drug laws, but I’m also in full support of people consuming their preferred drugs by whatever route of administration they see fit. Hopefully one of these days a snortable marijuana product will be available for consumers, but until then things are just going to keep moving a bit more slowly.

Wrapping up this month’s recap is an update on where Decriminalize Nature stands when it comes to peyote. You may recall that some Native American groups around the country have spoken out against the drug decriminalization movement including peyote in its recommendations for drugs to be decriminalized, and now Decrim Nature has officially announced a peyote conservation plan that is intended to work in tandem with the conservation strategy that is already underway.

Under this resolution, peyote found in its natural habit would be available only for indigenous communities and poaching would continue to be penalized, but the personal cultivation of peyote by non-indigenous people would be decriminalized, which would hopefully address the existing demand for the cacti and help assist with the ongoing conservation effort.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.